نتائج البحث 481-490 من 4876 لعملية البحث عن Blood factor II
prior chemotherapy or radiation exposure, cumulative radiotheranostic dose) with geneticclonal abnormalities (blood-based CHIP panel) in studying the ...
... blood DNA markers for inflammatory bowel disease ... In the phase II part, to evaluate the preliminary antitumor activity of two ... blood. Blood And ...
Determine risk factors for sarcoid involvement of the heart ... Thus, to determine if quantitative blood volume ... توجّه للصفحة 22 · توجّه للصفحة 33 · توجّه للصفحة 44 ...
Scottsdale/Phoenix, Ariz. This phase II trial tests whether an exercise intervention works to improve cognitive function in breast cancer survivors. Many breast ...
The investigators have chosen this population because 1) These mutations are the most common genetic causes of LQTS, and 2) Offspring will have high risk of ...
Human Blood and Tissues Repository for Neuroscience Research ... factors associated with onset of symptoms in MSA. ... توجّه للصفحة 22 · توجّه للصفحة 33 · توجّه للصفحة ...
In this study, some of the patient's T cells will be removed from their blood. ... Randomized Phase II/III Trial of Adjuvant ... Social Determinants Of Migrant ...
Given the theoretical risk of systemically re-infusing samples contaminated with tumor cells, many surgeons refrain from using intraoperative blood salvage.
The purpose of this study is to develop prognostic and diagnostic blood ... We further examine whether blood biomarkers can ... 2-year progression free survival ( ...
To develop a repository of blood, urine and ... This study will also help us to learn whether certain genes (inherited factors ... توجّه للصفحة 22 · توجّه للصفحة 33 ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.